Загрузка...
Management of Antiviral Resistance in Chronic Hepatitis B
The primary goal of therapy for chronic hepatitis B (CHB) is to prevent liver disease progression. Hepatitis B surface antigen (HBsAg) seroclearance or seroconversion is regarded as an optimal endpoint to discontinue treatment. However, HBsAg seroclearance occurs very rarely with nucleos(t)ide analo...
Сохранить в:
| Опубликовано в: : | Gut Liver |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Editorial Office of Gut and Liver
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347642/ https://ncbi.nlm.nih.gov/pubmed/28183162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl15562 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|